Nextech Trims Kymera at a Recent High — think Foolishly before acting.

Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified ...
Zacks.com on MSN

Can Rio Tinto's Pilbara Facility Fuel Its Near-Term Momentum?

Rio Tinto Group RIO delivered resilient iron ore performance in 2025, supported by strong execution across its Pilbara ...